HTD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Corcept Therapeutics Inc

Watchlist Manager

Watchlist

Price: 39.45 EUR Market Closed

Market Cap: €4.1B

C	Corcept Therapeutics Inc XMUN:HTD	US
K	Kadant Inc F:KDA	US
T	Tower Bersama Infrastructure Tbk PT SWB:6TB	ID
M	Metro AG XMUN:B4B	DE
M	Mitsubishi Logisnext Co Ltd TSE:7105	JP
D	Dampskibsselskabet Norden A/S DUS:D69	DK
	Toyota Motor Corp F:TOMA	JP
S	Schweizer Electronic AG F:SCE	DE
S	Shenzhen Textile Holdings Co Ltd SZSE:200045	CN
H	Hoist Finance AB (publ) LSE:0R65	SE
	Capri Holdings Ltd NYSE:CPRI	UK
W	Woolworths Holdings Ltd JSE:WHL	ZA
	Toyota Motor Corp F:TOM	JP
V	Viscofan SA XBER:VIS	ES
	SGS SA OTC:SGSOY	CH
I	Innocan Pharma Corp DUS:IP4	IL
	Ono Pharmaceutical Co Ltd OTC:OPHLF	JP
	Schibsted ASA F:XPGB	NO

Profitability Summary

Corcept Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Declining Gross Margin

99% > 98%

Low Operating Margin

Sustainable 3Y Average Operating Margin

19%

Declining Operating Margin

24% > 6%

Healthy Net Margin

13%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

23% > 13%

Exceptional Free Cash Flow Margin

19%

Strong 3Y Average Free Cash Flow Margin

26%

Declining Free Cash Flow Margin

27% > 19%

Positive ROE

15%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

43%

Declining ROIC

69% > 16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.